Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Acorda Therapeutics
(NQ:
ACOR
)
14.57
UNCHANGED
Streaming Delayed Price
Updated: 3:56 PM EDT, Sep 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
14.57
Bid (Size)
5.730 (2)
Ask (Size)
17.60 (2)
Prev. Close
14.57
Today's Range
14.57 - 14.57
52wk Range
0.2611 - 18.20
Shares Outstanding
1,242,098
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 30, 2023
Via
Benzinga
Performance
YTD
+1756.05%
+1756.05%
1 Month
+9.71%
+9.71%
3 Month
+15.73%
+15.73%
6 Month
+2328.33%
+2328.33%
1 Year
+4906.87%
+4906.87%
More News
Read More
5 Value Stocks To Watch In The Healthcare Sector
August 21, 2023
Via
Benzinga
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
August 08, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: “For The Fighters™”
August 02, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023
August 01, 2023
From
Acorda Therapeutics
Via
Business Wire
Tom Burns Elected to the Acorda Therapeutics Board of Directors
June 28, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
June 26, 2023
From
Acorda Therapeutics
Via
Business Wire
Why Semtech Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
June 08, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 08, 2023
Via
InvestorPlace
Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split
June 02, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
May 31, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A
May 30, 2023
From
Acorda Therapeutics
Via
Business Wire
Week In Review: BlissBio Announces Potential $2 Billion Deal With Eisai For HER2 ADC
May 13, 2023
Via
Talk Markets
Acorda Therapeutics Reports First Quarter 2023 Financial Results
May 11, 2023
From
Acorda Therapeutics
Via
Business Wire
3 Penny Stocks to Avoid as Interest Rates Rise in 2023
May 11, 2023
Via
InvestorPlace
Acorda Therapeutics to Make June 2023 $6.2 Million Interest Payment on Secured Debt in Cash
May 10, 2023
From
Acorda Therapeutics
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 09, 2023
Via
Benzinga
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
May 09, 2023
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 09, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
May 08, 2023
Via
Benzinga
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China
May 08, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda First Quarter 2023 Update: Webcast/Conference Call Scheduled for May 11, 2023
May 04, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Therapeutics to Present INBRIJA® Data at the American Academy of Neurology Annual Meeting
April 24, 2023
From
Acorda Therapeutics
Via
Business Wire
Acorda Launches INBRIJA® TV Commercial for Parkinson’s Awareness Month
April 03, 2023
From
Acorda Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.